Tian Wenjie, Mahmoudi Michael, Lhermusier Thibault, Kiramijyan Sarkis, Ota Hideaki, Chen Fang, Torguson Rebecca, Suddath William O, Satler Lowell F, Pichard Augusto D, Waksman Ron
MedStar Washington Hospital Center, 110 Irving Street, NW, Suite 4B-1, Washington DC 20010 USA.
J Invasive Cardiol. 2015 Sep;27(9):387-91.
The optimal technique for lesion preparation in heavily calcified coronary lesions (HCCL) prior to drug-eluting stent (DES) implantation has not been described. The aim of this study was to compare the clinical outcomes of lesion preparation with rotational atherectomy (ROTA), plain old balloon angioplasty (POBA), or cutting-balloon angioplasty (CBA) in patients with HCCL who were treated with DES.
The study cohort comprised 737 consecutive patients (874 lesions) who underwent RA (n = 264), POBA (n = 220), or CBA (n = 253) for HCCL at our institution and were treated with DES. Patients with mild or moderate calcified lesions, restenotic lesions, treatment with bare-metal stent (BMS), or history of prior coronary artery bypass graft (CABG) were excluded. The analyzed clinical parameters were the 1-month, 6-month, and 12-month rates of death (all-cause and cardiac), Q-wave myocardial infarction (MI), target-lesion revascularization (TLR), definite stent thrombosis (ST), and major adverse cardiac event (MACE), defined as the composite of death, Q-wave MI, or TLR.
The patients were well matched for their baseline characteristics except for age (RA = 71.9 ± 10.4 years; POBA = 68.0 ± 10.8 years; CBA = 68.7 ± 11.8 years; P<.001) and hypertension (RA = 90.9%; POBA = 80.9%; CBA = 84.2%; P=.01), which were different among the three cohorts. The three cohorts had similar clinical outcomes at both short-term and long-term follow-up. The 12-month results were all-cause death (RA = 9.8%; POBA = 8.2%; CBA = 4.5%; P=.18), cardiac death (RA = 3.1%; POBA = 2.5%; CBA = 1.3%; P=.61), Q-wave MI (RA = 0%; POBA = 0%; CBA = 0.7%; P>.99), TLR (RA = 5.2%; POBA = 3.5%; CBA = 3.9%; P=.76), ST (RA = 0%; POBA = 0%; CBA = 0.6%; P=.63) and MACE (RA = 14.6%; POBA = 12.3%; CBA = 8.3%; P=.20). The 1-year MACE-free survival rates were also similar among the three cohorts (log-rank P=.20).
A strategy of lesion preparation with RA, POBA, or CBA in HCCL may be associated with similar clinical outcomes in patients undergoing percutaneous intervention with DES. The RA group had a trend toward greater MACE, death, and TLR.
药物洗脱支架(DES)植入前,严重钙化冠状动脉病变(HCCL)的最佳病变预处理技术尚无描述。本研究旨在比较接受DES治疗的HCCL患者采用旋磨术(ROTA)、单纯球囊血管成形术(POBA)或切割球囊血管成形术(CBA)进行病变预处理的临床结局。
研究队列包括737例连续患者(874处病变),这些患者在我们机构接受了ROTA(n = 264)、POBA(n = 220)或CBA(n = 253)治疗HCCL,并接受了DES治疗。排除轻度或中度钙化病变、再狭窄病变、接受裸金属支架(BMS)治疗或既往有冠状动脉旁路移植术(CABG)病史的患者。分析的临床参数包括1个月、6个月和12个月的全因死亡和心源性死亡发生率、Q波心肌梗死(MI)、靶病变血运重建(TLR)、明确的支架血栓形成(ST)以及主要不良心脏事件(MACE),MACE定义为死亡、Q波MI或TLR的复合事件。
除年龄(ROTA = 71.9 ± 10.4岁;POBA = 68.0 ± 10.8岁;CBA = 68.7 ± 11.8岁;P<0.001)和高血压(ROTA = 90.9%;POBA = 80.9%;CBA = 84.2%;P = 0.01)外,三个队列的患者基线特征匹配良好,这两项指标在三个队列中有所不同。三个队列在短期和长期随访中的临床结局相似。各治疗组12个月的结果为:全因死亡(ROTA = 9.8%;POBA = 8.2%;CBA = 4.5%;P = 0.18)、心源性死亡(ROTA = 3.1%;POBA = 2.5%;CBA = 1.3%;P = 0.61)、Q波MI(ROTA = 0%;POBA = 0%;CBA = 0.7%;P>0.99)、TLR(ROTA = 5.2%;POBA = 3.5%;CBA = 3.9%;P = 0.76)、ST(ROTA = 0%;POBA = 零%;CBA = 0.6%;P = 0.63)和MACE(ROTA = 14.6%;POBA = 12.3%;CBA = 8.3%;P = 0.20)。三个队列的1年无MACE生存率也相似(对数秩检验P = 0.20)。
对于接受DES经皮介入治疗的HCCL患者,采用ROTA、POBA或CBA进行病变预处理的策略可能具有相似的临床结局。ROTA组有发生更多MACE、死亡和TLR的趋势。